COLLPLANT BIOTECH. IS-01 (F:CPT) — Stock Price
COLLPLANT BIOTECH. IS-01 (F:CPT) is currently trading at €0.27 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.15 and €1.83. This page tracks COLLPLANT BIOTECH. IS-01's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CPT market cap.
COLLPLANT BIOTECH. IS-01 (CPT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks COLLPLANT BIOTECH. IS-01's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
COLLPLANT BIOTECH. IS-01 Income Statement — Revenue, Profit & Earnings by Year
COLLPLANT BIOTECH. IS-01's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €2.37 Million | €515.00K | €10.96 Million | €299.00K | €15.64 Million |
| Cost of Revenue | €835.00K | €1.62 Million | €1.99 Million | €400.00K | €2.00 Million |
| Gross Profit | €1.54 Million | €-1.11 Million | €8.97 Million | €-101.00K | €13.64 Million |
| Research & Development | €8.19 Million | €10.52 Million | €10.48 Million | €10.26 Million | €7.63 Million |
| SG&A | €4.83 Million | €5.63 Million | €6.00 Million | €6.74 Million | €5.94 Million |
| Total Operating Expenses | €13.85 Million | €17.77 Million | €18.47 Million | €17.40 Million | €15.58 Million |
| Operating Income | €-11.48 Million | €-17.25 Million | €-7.51 Million | €-17.10 Million | €65.00K |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Before Tax | €-11.49 Million | €-16.61 Million | €-7.02 Million | €-16.93 Million | €237.00K |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-11.49 Million | €-16.61 Million | €-7.02 Million | €-16.93 Million | €237.00K |
COLLPLANT BIOTECH. IS-01 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes COLLPLANT BIOTECH. IS-01's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €10.79 Million | €18.71 Million | €34.13 Million | €37.77 Million | €51.22 Million |
| Total Current Assets | €6.75 Million | €13.18 Million | €28.02 Million | €31.66 Million | €45.09 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | €0.00 | €30.15 Million |
| Net Receivables | €1.00K | €150.00K | €0.00 | €9.00K | €270.00K |
| Inventory | €573.00K | €440.00K | €714.00K | €1.43 Million | €1.08 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €4.70 Million | €5.25 Million | €5.79 Million | €5.49 Million | €6.10 Million |
| Total Current Liabilities | €2.67 Million | €2.97 Million | €3.25 Million | €3.10 Million | €3.01 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €6.08 Million | €13.46 Million | €28.34 Million | €32.28 Million | €45.12 Million |
| Retained Earnings | €-124.84 Million | €-113.35 Million | €-96.74 Million | €-89.72 Million | €-72.80 Million |
COLLPLANT BIOTECH. IS-01 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how COLLPLANT BIOTECH. IS-01 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-9.42 Million | €-14.09 Million | €-2.76 Million | €-13.70 Million | €2.50 Million |
| Capital Expenditures | €28.00K | €483.00K | €954.00K | €1.32 Million | €1.59 Million |
| Free Cash Flow | €-9.45 Million | €-14.58 Million | €-3.72 Million | €-15.01 Million | €912.00K |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | €3.10 Million | €9.00K | €1.11 Million | €1.87 Million | €38.76 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €999.00K | €1.72 Million | €1.94 Million | €2.17 Million | €1.60 Million |
| Depreciation | €912.00K | €1.04 Million | €1.10 Million | €1.08 Million | €773.00K |
| Change in Cash | €-6.32 Million | €-14.77 Million | €-3.19 Million | €16.49 Million | €9.85 Million |
COLLPLANT BIOTECH. IS-01 Earnings History — EPS Actual vs. Analyst Estimates
Track COLLPLANT BIOTECH. IS-01's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 27, 2026 | — | -0.24 | — |
| Mar 25, 2026 | — | -0.19 | — |